The role of class III beta-tubulin in invasive potential of thyroid carcinoma and its clinical significance

被引：0
|
作者：
Na, H. Y. [1 ]
Choe, J-Y [1 ]
Shin, S. A. [1 ]
Park, M. [1 ]
Kim, J. E. [1 ]
机构：
[1] SNU Bundang Hosp, Pathol, Seongnam, Gyeonggi Do, South Korea
来源：
VIRCHOWS ARCHIV | 2018年 / 473卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
OFP-14-005
引用
收藏
页码：S46 / S46
页数：1
相关论文
共 50 条
  • [31] Clinical significance of class III β-tubulin expression and its predictive value for resistance to docetaxel-based chemotherapy in gastric cancer
    Urano, N
    Fujiwara, Y
    Doki, Y
    Kim, SJ
    Miyoshi, Y
    Noguchi, S
    Miyata, H
    Takiguchi, S
    Yasuda, T
    Yano, M
    Monden, M
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2006, 28 (02) : 375 - 381
  • [32] AXONAL-TRANSPORT OF CLASS-II AND CLASS-III BETA-TUBULIN - EVIDENCE THAT THE SLOW COMPONENT WAVE REPRESENTS THE MOVEMENT OF ONLY A SMALL FRACTION OF THE TUBULIN IN MATURE MOTOR AXONS
    HOFFMAN, PN
    LOPATA, MA
    WATSON, DF
    LUDUENA, RF
    JOURNAL OF CELL BIOLOGY, 1992, 119 (03): : 595 - 604
  • [33] The association of Snail expression with ERCC1 and beta-tubulin class III expression in cisplatin and paclitaxel resistance of lung cancer cells
    Hung, Jung-Jyh
    Wu, Kou-Juey
    CANCER RESEARCH, 2012, 72
  • [34] Expression of Class III Beta-Tubulin Correlates with Unfavorable Survival Outcome in Patients with Resected Non-small Cell Lung Cancer
    Koh, Youngil
    Jang, Bogun
    Han, Sae-Won
    Kim, Tae-Min
    Oh, Do-Youn
    Lee, Se-Hoon
    Kang, Chang Hyun
    Kim, Dong-Wan
    Im, Seock-Ah
    Chung, Doo Hyun
    Kim, Young Tae
    Kim, Tae-You
    Kim, Young-Whan
    Kim, Joo Hyun
    Heo, Dae Seog
    Bang, Yung-Jue
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (03) : 320 - 325
  • [35] Expression of thyroid stimulating hormone receptor in differentiated thyroid carcinoma and its clinical significance
    李清怀
    ChinaMedicalAbstracts(InternalMedicine), 2013, 30 (04) : 207 - 207
  • [36] MutL homolog 1 expression in thyroid carcinoma and its clinical significance
    Lu, Yi
    Jiang, Baocheng
    Yuan, Ye
    Fei, Jianping
    Wang, Jiyuan
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2016, 12 (08) : 281 - 283
  • [37] Expression of class III beta-tubulin (TUBB3) in 3580 colorectal cancers (CRCs) and correlation with clinico-pathological and molecular features
    Xiu, Joanne
    Reddy, Sandeep
    Ei-Deiry, Wafik S.
    CANCER RESEARCH, 2016, 76
  • [38] High-titer immunoglobulin M antibody to nerve-specific class III beta-tubulin in the serum of a patient with sensory demyelinating polyneuropathy
    Stubbs, EB
    Fisher, MA
    Wilson, JR
    Siegel, GJ
    MUSCLE & NERVE, 1996, 19 (12) : 1638 - 1639
  • [39] A CYTOMORPHOLOGICAL SCHEME OF DIFFERENTIATING NEURONAL PHENOTYPES IN CEREBELLAR MEDULLOBLASTOMAS BASED ON IMMUNOLOCALIZATION OF CLASS-III BETA-TUBULIN ISOTYPE (BETA-III) AND PROLIFERATING CELL NUCLEAR ANTIGEN (PCNA) CYCLIN
    KATSETOS, CD
    KRISHNA, L
    FRANKFURTER, A
    KARKAVELAS, G
    WOLFE, DE
    VALSAMIS, MP
    SCHIFFER, D
    VLACHOS, IN
    URICH, H
    CLINICAL NEUROPATHOLOGY, 1995, 14 (02) : 72 - 81
  • [40] Class III beta tubulin overexpression is a marker of poor clinical outcome in advanced ovarian cancer patients
    Ferrandina, Gabriella
    Ferlini, Cristiano
    Martinelli, Enrica
    Zannoni, Gian Franco
    Legge, Francesco
    Riva, Antonella
    Manzotti, Carla
    Paglia, Amelia
    Scambia, Giovanni
    CANCER RESEARCH, 2006, 66 (08)
12345